← Evidence map

ArticleJAMA health forum2024

Use, Spending, and Prices of Adalimumab Following Biosimilar Competition.

Benjamin N Rome et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39671204